Covered recipient · General Payments record
KRISTIN M GOLDEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,367.25
- Reported across 62 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $338.75 | 16 |
| Education | $154.98 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $179.58 | 5 |
| Tempus AI, Inc | $100.00 | 1 |
| Novo Nordisk AS | $85.09 | 5 |
| Exact Sciences Corporation | $61.39 | 4 |
| Sumitomo Pharma America, Inc. | $26.13 | 1 |
| Acerta Pharma LLC | $25.63 | 1 |
| Lilly USA, LLC | $15.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $25.63 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104498702 | CMS |
| Exact Sciences Corporation | $15.72 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114517684 | CMS |
| Exact Sciences Corporation | $17.40 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114517689 | CMS |
| Exact Sciences Corporation | $13.72 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114517695 | CMS |
| Exact Sciences Corporation | $14.55 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114517699 | CMS |
| Lilly USA, LLC | $15.91 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135749989 | CMS |
| Novo Nordisk Inc | $15.83 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100500681 | CMS |
| Novo Nordisk Inc | $25.00 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100281518 | CMS |
| Novo Nordisk Inc | $13.76 | 08/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100635769 | CMS |
| Novo Nordisk Inc | $16.23 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100236938 | CMS |
| Novo Nordisk Inc | $14.27 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100382015 | CMS |
| PFIZER INC. | $84.99 | 01/17/2024 | Education | Undisputed | 01/23/2026 | 1131467988 | CMS |
| PFIZER INC. | $69.99 | 01/17/2024 | Education | Undisputed | 01/23/2026 | 1131469053 | CMS |
| PFIZER INC. | $9.08 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131243093 | CMS |
| PFIZER INC. | $12.05 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131243089 | CMS |
| PFIZER INC. | $3.47 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131245185 | CMS |
| Sumitomo Pharma America, Inc. | $26.13 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148963098 | CMS |
| Tempus AI, Inc | $100.00 | 06/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150181493 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.